View in EDS

Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST.

Saved in:
Bibliographic Details
Title: Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST.
Authors: Takahashi N; Department of Hematology, Nephrology, and Rheumatology, Akita University School of Medicine, Akita, Akita, Japan. naotot@doc.med.akita-u.ac.jp., Kikushige Y; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Fukuoka, Japan., Nakamae H; Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Osaka, Japan., Goto T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Aichi, Japan., Tomita A; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Ichii M; Department of Hematology and Oncology, Osaka University Hospital, Suita, Osaka, Japan., Ito S; Department of Hematology, Yamagata University Hospital, Yamagata, Yamagata, Japan., Teshima T; Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Hokkaido, Japan., Kirito K; Department of Hematology and Oncology, University of Yamanashi, Chuo, Yamanashi, Japan., Ikezoe T; Department of Hematology, Fukushima Medical University, Fukushima, Fukushima, Japan., Hatano K; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan., Tanaka H; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan., Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan., Osako R; Novartis Pharma K.K., Tokyo, Japan., Aoki M; Novartis Pharma K.K., Tokyo, Japan., Malek K; Novartis Pharma AG, Basel, Switzerland., Ueda Y; Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
Source: International journal of hematology [Int J Hematol] 2025 Nov; Vol. 122 (5), pp. 647-659. Date of Electronic Publication: 2025 May 26.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40418277
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Takahashi+N%22">Takahashi N</searchLink>; Department of Hematology, Nephrology, and Rheumatology, Akita University School of Medicine, Akita, Akita, Japan. naotot@doc.med.akita-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Kikushige+Y%22">Kikushige Y</searchLink>; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Nakamae+H%22">Nakamae H</searchLink>; Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Goto+T%22">Goto T</searchLink>; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Tomita+A%22">Tomita A</searchLink>; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Ichii+M%22">Ichii M</searchLink>; Department of Hematology and Oncology, Osaka University Hospital, Suita, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Ito+S%22">Ito S</searchLink>; Department of Hematology, Yamagata University Hospital, Yamagata, Yamagata, Japan.<br /><searchLink fieldCode="AU" term="%22Teshima+T%22">Teshima T</searchLink>; Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Hokkaido, Japan.<br /><searchLink fieldCode="AU" term="%22Kirito+K%22">Kirito K</searchLink>; Department of Hematology and Oncology, University of Yamanashi, Chuo, Yamanashi, Japan.<br /><searchLink fieldCode="AU" term="%22Ikezoe+T%22">Ikezoe T</searchLink>; Department of Hematology, Fukushima Medical University, Fukushima, Fukushima, Japan.<br /><searchLink fieldCode="AU" term="%22Hatano+K%22">Hatano K</searchLink>; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.<br /><searchLink fieldCode="AU" term="%22Tanaka+H%22">Tanaka H</searchLink>; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Hiramoto+N%22">Hiramoto N</searchLink>; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.<br /><searchLink fieldCode="AU" term="%22Osako+R%22">Osako R</searchLink>; Novartis Pharma K.K., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Aoki+M%22">Aoki M</searchLink>; Novartis Pharma K.K., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Malek+K%22">Malek K</searchLink>; Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ueda+Y%22">Ueda Y</searchLink>; Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229111627%22">International journal of hematology</searchLink> [Int J Hematol] 2025 Nov; Vol. 122 (5), pp. 647-659. <i>Date of Electronic Publication: </i>2025 May 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Japan%22">Springer Japan </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9111627 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-3774 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209255710%22">09255710 </searchLink><i>NLM ISO Abbreviation: </i>Int J Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40418277
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12185-025-04014-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 647
    Titles:
      – TitleFull: Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Takahashi N
      – PersonEntity:
          Name:
            NameFull: Kikushige Y
      – PersonEntity:
          Name:
            NameFull: Nakamae H
      – PersonEntity:
          Name:
            NameFull: Goto T
      – PersonEntity:
          Name:
            NameFull: Tomita A
      – PersonEntity:
          Name:
            NameFull: Ichii M
      – PersonEntity:
          Name:
            NameFull: Ito S
      – PersonEntity:
          Name:
            NameFull: Teshima T
      – PersonEntity:
          Name:
            NameFull: Kirito K
      – PersonEntity:
          Name:
            NameFull: Ikezoe T
      – PersonEntity:
          Name:
            NameFull: Hatano K
      – PersonEntity:
          Name:
            NameFull: Tanaka H
      – PersonEntity:
          Name:
            NameFull: Hiramoto N
      – PersonEntity:
          Name:
            NameFull: Osako R
      – PersonEntity:
          Name:
            NameFull: Aoki M
      – PersonEntity:
          Name:
            NameFull: Malek K
      – PersonEntity:
          Name:
            NameFull: Ueda Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1865-3774
          Numbering:
            – Type: volume
              Value: 122
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: International journal of hematology
              Type: main
ResultId 1